The iOS version of the LDL cholesterol app has been completed.

Our company has been engaged in the development of measurement technology for completely non-contact, non-invasive blood testing information based on mathematical sciences for over a decade. On August 29, 2025, we will present our technology at the national conference of the Japanese Society of Laboratory Medicine. Starting from the end of September 2025, we will …

Exhibition/Presentation at the Medical Conference Forum

Our company presented a study on the non-contact, non-invasive measurement of HbA1c at the Annual Meeting of the Japan Society of Clinical Chemistry held on August 29, 2025. By the end of September 2025, we released an Android application, “FLD HbA1c,” through the SFM App Store, and we are currently offering the app in 18 …

Website Renewal

We have released “FLD HbA1c” on our app store, “SFM App Store,” since the end of September 2025. With increasing attention from overseas, we have significantly revamped our website on December 2, 2025, to enable global accessibility. In 2026, we aim to further contribute to the world with presentations on LDL cholesterol at academic conferences, …

The Android version of the LDL Cholesterol App has been completed.

For over ten years, our company has been developing technology for completely non-contact and non-invasive blood test information measurement, grounded in mathematical and neuroscientific principles. On August 29, 2025, we will present our technology at the Annual Meeting of the Japanese Association of Clinical Laboratory Medicine, and starting from the end of September 2025, we …

We have increased the number of foreign countries where FLD HbA1c is available.

After extensive foundational research, SFM Corporation independently developed the Android app “FLD HbA1c,” which was launched in seven countries across Southeast and Southwest Asia on October 22, 2025. Subsequently, it was released in five countries within the Asia-Oceania region on November 3, 2025, and in four countries within the Asia-Central America region on November 16, …

Regarding Our Subscription

Since the end of September 2025, we have been releasing our independently developed FLD HbA1c app on the SFM App Store, following many years of foundational research. This app adopts a subscription model. Given the increasing issues related to subscription cancellations in recent years, we would like to take this opportunity to explain our cancellation …